2-Bromo-1,4-Bis-(2-aza-1-oxo-8-(sodium(5-acetamido-3,5,9-trideoxy-9-(4-phenylbenzamido)-D-glycero-alpha-D-galacto-non-2-ulopyranosyloxyonate))-5-thia-octyl)benzene

ID: ALA5178507

Chembl Id: CHEMBL5178507

PubChem CID: 168275896

Max Phase: Preclinical

Molecular Formula: C66H77BrN6Na2O20S2

Molecular Weight: 1420.42

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CNC(=O)c2ccc(-c3ccccc3)cc2)O[C@@](OCCCSCCNC(=O)c2ccc(C(=O)NCCSCCCO[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)c4ccc(-c5ccccc5)cc4)O3)c(Br)c2)(C(=O)[O-])C[C@@H]1O.[Na+].[Na+]

Standard InChI:  InChI=1S/C66H79BrN6O20S2.2Na/c1-38(74)72-53-49(76)34-65(63(86)87,92-57(53)55(80)51(78)36-70-59(82)44-19-15-42(16-20-44)40-11-5-3-6-12-40)90-27-9-29-94-31-25-68-61(84)46-23-24-47(48(67)33-46)62(85)69-26-32-95-30-10-28-91-66(64(88)89)35-50(77)54(73-39(2)75)58(93-66)56(81)52(79)37-71-60(83)45-21-17-43(18-22-45)41-13-7-4-8-14-41;;/h3-8,11-24,33,49-58,76-81H,9-10,25-32,34-37H2,1-2H3,(H,68,84)(H,69,85)(H,70,82)(H,71,83)(H,72,74)(H,73,75)(H,86,87)(H,88,89);;/q;2*+1/p-2/t49-,50-,51+,52+,53+,54+,55+,56+,57+,58+,65+,66+;;/m0../s1

Standard InChI Key:  WUVAYLONLNXMTR-OKQIABBQSA-L

Associated Targets(Human)

CD22 Tclin CD22 (125 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1420.42Molecular Weight (Monoisotopic): 1418.3974AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Prescher H, Schweizer A, Frank M, Kuhfeldt E, Ring J, Nitschke L..  (2022)  Targeting Human CD22/Siglec-2 with Dimeric Sialosides as Novel Oligosaccharide Mimetics.,  65  (15.0): [PMID:35881556] [10.1021/acs.jmedchem.2c00765]

Source